Sterling Investment Counsel, LLC

Position in JNJ — Johnson & Johnson

CIK 1925853 Buffalo, NY

Position in JNJ

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$1,059,562

+$44,892 QoQ

Shares Held

4,172

+0.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

#2,973

of 4,676 holders

Holding Since

Dec 2021

17 quarters on record

Voting authority Sole 88% Shared 0% None 12%

Healthcare · as of Jun 30, 2026

Sterling Investment Counsel, LLC holds $9,362,958 across 6 Drug Manufacturers - General names. JNJ ranks #5 (11.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,327	$2,791,073
2	ABBV	AbbVie Inc.	9,241	$2,325,405
3	MRK	Merck & Co., Inc.	13,344	$1,714,704
4	GILD	Gilead Sciences, Inc.	9,013	$1,138,702
5	JNJ	Johnson & Johnson This page	4,172	$1,059,562
6	AMGN	Amgen Inc	921	$333,512

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,059,562	4,172	+0.5%	Shares	Sole	2026-07-20
2026-03-31	$1,014,670	4,151	+1.1%	Shares	Sole	2026-04-16
2025-12-31	$849,736	4,106	-0.8%	Shares	Sole	2026-01-27
2025-09-30	$767,638	4,140	-1.7%	Shares	Sole	2025-10-21
2025-03-31	$698,186	4,210	-8.4%	Shares	Sole	2025-04-21
2024-09-30	$744,503	4,594	+0.0%	Shares	Sole	2024-10-22
2024-06-30	$671,166	4,592	-3.3%	Shares	Sole	2024-07-25
2024-03-31	$751,244	4,749	+0.3%	Shares	Sole	2024-04-26
2023-12-31	$742,163	4,735	-11.7%	Shares	Sole	2024-01-12
2023-09-30	$835,287	5,363	-13.1%	Shares	Sole	2023-10-19
2023-06-30	$1,021,258	6,170	-5.9%	Shares	Sole	2023-07-17
2023-03-31	$1,016,800	6,560	+6.4%	Shares	Sole	2023-04-18
2022-12-31	$1,088,693	6,163	-1.2%	Shares	Sole	2023-01-20
2022-09-30	$1,019,039	6,238	-2.5%	Shares	Sole	2022-10-21
2022-06-30	$1,136,241	6,401	-0.8%	Shares	Sole	2022-10-20
2022-03-31	$1,143,487	6,452	+44.9%	Shares	Sole	2022-05-10
2021-12-31	$761,774	4,453	—	Shares	Sole	2022-04-29
No filing history on record for this holder in this stock.